(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 0.00%
0.49% ¥ 1 018.00
Live Chart Being Loaded With Signals
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system...
Stats | |
---|---|
Tagesvolumen | 29 500.00 |
Durchschnittsvolumen | 93 615.00 |
Marktkapitalisierung | 26.11B |
EPS | ¥19.18 ( 2024-02-13 ) |
Nächstes Ertragsdatum | ( ¥0 ) 2024-05-08 |
Last Dividend | ¥4.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 24.63 |
ATR14 | ¥1.412 (0.14%) |
Volumen Korrelation
FINDEX Inc. Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
FINDEX Inc. Korrelation - Währung/Rohstoff
FINDEX Inc. Finanzdaten
Annual | 2023 |
Umsatz: | ¥5.19B |
Bruttogewinn: | ¥3.33B (64.13 %) |
EPS: | ¥41.31 |
FY | 2023 |
Umsatz: | ¥5.19B |
Bruttogewinn: | ¥3.33B (64.13 %) |
EPS: | ¥41.31 |
FY | 2022 |
Umsatz: | ¥4.54B |
Bruttogewinn: | ¥2.72B (59.96 %) |
EPS: | ¥28.21 |
FY | 2021 |
Umsatz: | ¥4.97B |
Bruttogewinn: | ¥2.56B (51.45 %) |
EPS: | ¥20.24 |
Financial Reports:
No articles found.
FINDEX Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥6.50 (N/A) |
¥0 (N/A) |
¥4.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥0.250 | 2011-12-28 |
Last Dividend | ¥4.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 23 | -- |
Total Paid Out | ¥74.42 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.56 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.25 | |
Div. Directional Score | 7.75 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
7917.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7122.T | Ex Dividend Junior | 2024-03-28 | Sporadic | 0 | 0.00% | |
6384.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
5333.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4386.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3546.T | Ex Dividend Junior | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
2782.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
1332.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9678.T | Ex Dividend Knight | 2023-10-30 | Semi-Annually | 0 | 0.00% | |
8630.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.204 | 1.500 | 5.92 | 8.88 | [0 - 0.5] |
returnOnAssetsTTM | 0.178 | 1.200 | 4.05 | 4.86 | [0 - 0.3] |
returnOnEquityTTM | 0.243 | 1.500 | 8.41 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 6.48 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 5.97 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.32 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0558 | -1.500 | 9.07 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 2 394.51 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 6.53 | [0 - 30] |
freeCashFlowPerShareTTM | 20.20 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0685 | -1.500 | 9.73 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.641 | 1.000 | 2.64 | 2.64 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.288 | 1.000 | 6.23 | 6.23 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.564 | 1.000 | 2.42 | 2.42 | [0.2 - 2] |
assetTurnoverTTM | 0.875 | 0.800 | 7.50 | 6.00 | [0.5 - 2] |
Total Score | 11.26 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.65 | 1.000 | 7.61 | 0 | [1 - 100] |
returnOnEquityTTM | 0.243 | 2.50 | 8.98 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.277 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 20.20 | 2.00 | 3.27 | 6.53 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.817 | 1.500 | 1.220 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0998 | 1.000 | -0.00558 | 0 | [0.1 - 0.5] |
Total Score | 4.25 |
FINDEX Inc.
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.